The efficacy, tolerance and safety of calcium lactogluconate in the treatment of osteopenia and osteoporosis in the developmental age. Part 2. evaluation of calcium-phosphate metabolism and bone turnover markers

Journal Title: Przegląd Pediatryczny - Year 2007, Vol 37, Issue 3

Abstract

The aim of the study was to evaluate the influence of calcium lactogluconate treatment on calcium-phosphate metabolism indices and bone metabolic markers in children with osteoporosis and osteopenia. Material and methods. The study comprised 100 patients aged 5-19 years with low bone mass: in 40 - osteoporosis and in 60 - osteopenia was diagnosed. In the treatment calcium lactogluconate (Calcium 500D preparation) was used. The doses differed depending on diagnosis and progression of bone mineralization decrease. Before and after 12 months of treatment the serum con-centrations and urine elimination of calcium, phosphorus and magnesium ions were performed. The concentrations of parathormon, liver metabolite of vitamin D — 25OHD and bone metabolism markers: collagen type I crosslinked N-teolpeptide (NTX) and bone isoenzyme of alkaline phosphatase were also determined. Results: Statistically significant differences in calcium and magnesium concentrations before and after treatment were found, but they were within normal range. Increase of hypercalciuria was not observed. In children with significant deficiency of vitamin D an increase of 25OHD concentration back to normal range, after treatment, was found. Mild acceleration of bone formation - increase of bone isoenzyme of alkaline phosphatase, in children with osteoporosis was revealed. In all patients a decrease of NTX urine elimination (bone resorption marker) was observed, especially evident in children with osteoporosis. Conclusions 1. Calcium lactogluconate preparation has positive influence on calcium-phosphate metabolism and bone turnover markers in children during intensive growth. 2. Evaluation of bone turnover markers points on, that calcium lactogluconate inhibits bone resorption, which supports physiolo- gical prevalence of bone formation processes. Usage of this preparation in the developmental age could be a part of prevention of perimenopausal and involution osteoporosis.

Authors and Affiliations

Elżbieta Jakubowska-Pietkiewicz, Danuta Chlebna-Sokół, Agnieszka Rusińska, Izabela Michałus, Jolanta Frasunkiewicz, Katarzyna Kulińska-Szukalska, Beata Romanowska-Pietrasiak

Keywords

Related Articles

Niekorzystny przebieg rzadkiego mięsaka tkanek miękkich u chłopca z chorobą Recklinghausena

Chorzy z neurofibromatozą typu 1 (NF1) mają zwiększoną skłonność do zachorowania na nowotwory. W skojarzeniu z NF1 zanotowano również występowanie rzadkiego nowotworu, wywodzącego się z komórek Schwanna - malignant perip...

CLINICAL PICTURE AND FREQUENCY OF PNEUMONIA CAUSED BY CHLAMYDIA TRACHOMATIS IN CHILDREN AT THE AGE OF 1 TO 36 MONTHS – ANALYSIS 

Introduction: Chlamydia trachomatis is a common infectious pathogen causing many diseases within various organs and systems. In the youngest patients it is, among others, a cause of pneumonia with very different clinical...

Ocena materiałów zespalających służących do stabilizacji śródszpikowej złamań kości udowej u dzieci

Wprowadzenie: W pracy przedstawiono obserwacje poparte badaniami metalograficznymi, w oparciu o materiał własny, uszkodzeń korozyjnych i mechanicznych implantów stalowych użytych do zespolenia złamania kości udowej u dzi...

Invasive fungal infection during intensive chemotherapy in children with Nijmegen breakage syndrome - two cases report

Nijmegen breakage syndrome (NBS) patients treated for malignancies face a substantial risk of severe fungal infections caused by immunodeficiency characteristic for these patients. We report two cases of female patients...

LEJKOWATA KLATKA PIERSIOWA U DZIECI 

Niniejsza praca jest poświęcona klinicznej problematyce lejkowatej klatki piersiowej u dzieci. Wada ta jest jedną z najczęstszych wrodzonych deformacji przedniej ściany klatki piersiowej. Etiologii jej upatruje się w zab...

Download PDF file
  • EP ID EP82755
  • DOI -
  • Views 61
  • Downloads 0

How To Cite

Elżbieta Jakubowska-Pietkiewicz, Danuta Chlebna-Sokół, Agnieszka Rusińska, Izabela Michałus, Jolanta Frasunkiewicz, Katarzyna Kulińska-Szukalska, Beata Romanowska-Pietrasiak (2007). The efficacy, tolerance and safety of calcium lactogluconate in the treatment of osteopenia and osteoporosis in the developmental age. Part 2. evaluation of calcium-phosphate metabolism and bone turnover markers. Przegląd Pediatryczny, 37(3), 273-278. https://europub.co.uk/articles/-A-82755